Anest. intenziv. Med. 2013;24(3):163-167

Sugammadex for active reversal of neuromuscular blockade induced by rocuronium for Caesarean section in general anaesthesia - series of case reportsAnaesthesiology - Case Reports

Štourač Petr1,*, Kosinová Martina1, Bártíková Ivana1, Klučka Jozef1, Křikava Ivo1, Štoudek Roman1, Harazim Hana1, Huser Martin2, Janků Petr2, Gál Roman1
1 Klinika anesteziologie, resuscitace a intenzivní medicíny FN Brno a LF MU, Brno
2 Gynekologicko-porodnická klinika FN Brno a LF MU, Brno

Sugammadex is a selective relaxant-binding agent, which reverses rocuronium-induced neuromuscular blocks of any depth. We reported six Caesarean sec-tion cases undergoing general anaesthesia with propofol(1.6-2.3 mg/kg) or thiopental (4.1-5.6 mg/kg) and rocuronium (0.8-1.1 mg/kg) or sukcinylcholin(1.0-1.5 mg/kg) for the induction of neuromuscular blockade. Rocuronium was used for the maintenance of neromuscular blockade (0.4-0.5 mg/kg). At the end of the procedure, all the patients had a significant degree of neuromuscular block. In one patient, there was no single twitch response and no TOF-ratio, three patients had shallow neuromuscular blockade (TOF > 1) and two of them had no clinical signs of neuromuscular recovery (TOF monitoring not used). The same single dose of sugammadex 200 mg (1.7-3.2 mg/kg) was given. In all patients, sugammadex provided rapid and sufficient reversal to full muscle strenght. All patients were monitored after the operation and no signs of recurarization or neuromuscular weakness were observed.

Keywords: sugammdex; Caesarean section; general anaesthesia; neuromusclar blockade; Rapid Sequence Induction

Received: January 26, 2013; Accepted: February 26, 2013; Published: June 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štourač P, Kosinová M, Bártíková I, Klučka J, Křikava I, Štoudek R, et al.. Sugammadex for active reversal of neuromuscular blockade induced by rocuronium for Caesarean section in general anaesthesia - series of case reports. Anest. intenziv. Med. 2013;24(3):163-167.
Download citation

References

  1. Štourač, P. Obstetric Anaesthesia and Analgesia Month Attributes - reálná zpráva o anesteziologické praxi na českých porodních odděleních. Anest. intenziv. Med., 24, 2013, 2, s. 81-82.
  2. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 2011;118 (Suppl 1), p. 1-203. Go to original source... Go to PubMed...
  3. Sharp, L. M., Levy, D. M. Rapid sequence induction in obstetrics revisited. Curr. Opin. Anaesthesiol., 2009, Jun, 22, 3, p.: 357-361. Go to original source... Go to PubMed...
  4. McIver, T., Jolley, D., Pescod, D. General anaesthesia and Caesarean section for a patient with hereditary spastic paraparesis (Strumpell's disease). Int. J. Obstet. Anesth., 2007, 16, p.: 190-191. Go to original source... Go to PubMed...
  5. Stourac, P., Krikava, I., Seidlova, J., Strazevska, E., Huser, M., Hruban, L., Janku, P., Gal, R. Sugammadex in a parturient with myotonic dystrophy. Br. J. Anaesth., 2013, Apr, 110, 4, p.: 657-658, doi: 10.1093/bja/aet037. Go to original source... Go to PubMed...
  6. Garcia, V., Diemunsch, P., Boet, S. Use of rokuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis. Int. J. Obstet. Anesth., 2012, Jul, 21, 3, p.: 286-287, doi: 10.1016/j.ijoa.2012.02.006. Go to original source... Go to PubMed...
  7. Abu-Halaweh, S. A., Massad, I. M., Abu-Ali, H. M. et al. Rapid sequence induction and intubation with 1 mg/kg rokuronium bromide in cesarean section: Comparison with suxamethonium. Saudi Med. J., 2007, 28, p.: 1393-1396. Go to PubMed...
  8. Puhringer, F. K., Kristen, P., Rex, C. Sugammadex reversal of rokuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases. Br. J. Anaesth., 2010, 105,p.: 657-660. Go to original source... Go to PubMed...
  9. Murdoch, H., Scrutton, M., Laxton, Ch. Choice of anaesthetic agents for caesarean section: A UK survey of current practice. Int. J. Obstet. Anesth., 2013, Jan. 22, 1, p.: 31-35, doi: 10.1016/j.ijoa.2012.09.001. Go to original source... Go to PubMed...
  10. Státní ústav pro kontrolu léčiv 2013: SPC přípravku Bridion™ [citováno online 20. 2. 2013]. Dostupné z www: <http://www.sukl.cz/modules/medication/detail.php?code=0500226&tab=texts>
  11. Williamson, R. M., Mallaiah, S., Barclay, P. Rokuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand., 2011, 55, p.: 694-699. Go to original source... Go to PubMed...
  12. Státní ústav pro kontrolu léčiv 2013: SPC přípravku Esmeron™ [citováno online 20. 2. 2013]. Dostupné z www: <http://www.sukl.cz/modules/medication/detail.php?code=0031932&tab=texts >
  13. Shibusawa, M., Ejima, Y., Nishino, R., Toyama, H.,Kurosawa, S. Use of sugammadex in patients undergoingcaesarean section using general anesthesia with rokuronium. Masui., 2012, Aug, 61, 8, p.: 805-809. Go to PubMed...
  14. Nauheimer, D., Kollath, C., Geldner, G. Modified rapid sequence induction for Caesarian sections : case series on the use of rocuronium and sugammadex. Anaesthesist., 2012, Aug, 61, 8, p.: 691-695, doi: 10.1007/s00101-012-2065-6. Go to original source... Go to PubMed...
  15. Llauradó, S., Sabaté, A., Ferreres, E., Camprubí, I., Cabrera, A.Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology, 2012, Jul, 117, 1, p.: 93-98, doi: 10.1097/ALN.0b013e3182580409. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.